TAK-701
/ Galaxy Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 31, 2012
Development activities: Discontinued projects
(Takeda)
- TAK-701 discontinued in Advanced malignancies; The decision to discontinue development was made because it no longer fits in the product development portofolio of Takeda.
Discontinued • Oncology
1 to 1
Of
1
Go to page
1